Delivery Order SPE2DB22D1106-SPE2DB25FEGB8

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,743.38, is for the delivery of Armour Thyroid 60 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of September 11, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Armour Thyroid 90 mg tablets. The contract has a ceiling value of $6,662.72 and runs through January 21, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,316.15 firm fixed-price contract is for the supply of Armour Thyroid 30 mg tablets. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen is the prime contractor, and there is no indication of any subcontractors. The contract is not associated with any set-aside designation, implying open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Armour Thyroid 120 mg tablets, a prescription medication, valued at $2,791.56. The contract has an ultimate completion date of October 18, 2023 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Armour Thyroid 90 mg tablets and has a ceiling value of $3,716.15. The contract is a firm fixed price contract with a completion date of March 6, 2025. This contract award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,020.58, is for the delivery of Armour Thyroid 60 mg tablets in quantities of 100 per bottle. The contract is a firm fixed-price, delivery order contract with a performance period ending on May 31, 2024. This award is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Armour Thyroid 120 MG tablets. The contract, valued at $2,550.60, has a firm fixed price pricing type and an ultimate completion date of September 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various federal agencies. This contract is likely part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Armour Thyroid 240 mg tablets, a specialty medication, and has a ceiling value of $1,612.56. It is a firm-fixed-price contract with an ultimate completion date of August 30, 2023. This award is a child contract under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,488.10 and is for the supply of Armour Thyroid 90 mg tablets. The contract has an ultimate completion date of November 16, 2023 and was awarded on November 15, 2023. No set-aside designation was used for this contract. AmerisourceBergen holds a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical sourcing and distribution company AmerisourceBergen Corporation. The contract, valued at $3,230.94, is for the provision of Armour Thyroid 60 mg tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEGB8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,022.12, is for the supply of Armour Thyroid 90 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/2/25, 10:57 PM